Anti-fibrotic activity of Irbesartan in chronic hepatitis with hypertension using Elastography.

Trial Profile

Anti-fibrotic activity of Irbesartan in chronic hepatitis with hypertension using Elastography.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 25 Feb 2016 Status changed from recruiting to active, no longer recruiting.
    • 14 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top